Profile data is unavailable for this security.
About the company
DSwiss, Inc. is a beauty supply company. The Company sells cosmetics and other related beauty products to consumers in Malaysia with focus to expand around the world. The Company, through its subsidiaries, supplies beauty products directly to clients. The Company operates through two segment in Malaysia and Hong Kong. The Company's beauty supplies include beverages to assist in burning and reducing fat, anti-aging creams, and products designed to improve the overall health and physical appearance of its clients. The Company's subsidiaries include DSwiss Holding Limited, which is engaged in investment holding, and its DSwiss (HK) Limited and DSwiss Sdn Bhd are engaged in supply of beauty products. The Company has a domain, www.dswissbeauty.com. The Company's products include Coffee Plus, Kiwi Cell Detox, Triple Stem Cell, Silk Mask, Coffee Slimming Scrub and Peppermint Slimming Gel.
- Revenue in USD (TTM)1.35m
- Net income in USD7.67k
- Incorporated2015
- Employees6.00
- LocationDswiss Inc59200 Kuala LumpurPETALING JAYA 59200MalaysiaMYS
- Phone+60 327704032
- Websitehttp://dswissbeauty.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca Pharma India Ltd | 108.90m | 10.31m | 1.31bn | 1.33k | 127.07 | -- | 101.73 | 12.04 | 30.24 | 30.24 | 319.28 | -- | -- | -- | -- | 6,024,223.00 | -- | 7.27 | -- | 14.20 | 62.65 | 60.23 | 9.47 | 5.48 | -- | 82.71 | -- | 0.00 | 14.21 | 9.98 | 32.62 | -- | -9.79 | -- |
| Mayinglong Pharmaceutical Group Co Ltd | 515.35m | 66.33m | 1.35bn | 3.09k | 20.38 | 2.94 | -- | 2.62 | 0.9905 | 0.9905 | 7.70 | 6.86 | 0.8912 | 6.78 | 21.79 | 1,073,238.00 | 11.96 | 10.21 | 15.04 | 12.68 | 38.11 | 42.11 | 13.42 | 12.91 | 3.85 | -- | 0.0777 | 32.21 | 3.19 | 9.37 | 16.42 | 13.42 | -18.19 | 8.45 |
| Heron Therapeutics Inc | 83.26m | -228.31m | 1.41bn | 223.00 | -- | 6.45 | -- | 16.94 | -2.51 | -2.51 | 0.9147 | 2.15 | 0.2108 | 0.8977 | 2.27 | 373,345.30 | -57.81 | -64.47 | -77.11 | -86.80 | 58.23 | 62.24 | -274.23 | -285.21 | 2.28 | -- | 0.0371 | -- | -39.28 | -- | -11.00 | -- | 44.38 | -- |
| Luckwel Pharmaceuticals Inc | 0.00 | -366.21k | 1.43bn | -- | -- | -- | -- | -- | -0.0026 | -0.0026 | 0.00 | -0.0082 | 0.00 | -- | -- | -- | -808.95 | -726.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -15.91 | -- | -- | -- |
| The United Laboratories Intl. Hldgs Ltd. | 1.36bn | 108.98m | 1.59bn | 13.00k | 14.18 | 1.19 | 7.77 | 1.17 | 0.4719 | 0.4719 | 5.98 | 5.64 | 0.5722 | 3.31 | 3.31 | 812,611.40 | 4.57 | 2.47 | 7.25 | 4.20 | 43.39 | 40.29 | 7.99 | 4.88 | 1.40 | 3.03 | 0.2043 | 24.07 | 4.53 | 7.06 | 9.54 | 51.04 | -3.00 | -- |
| Clinigen Group PLC | 731.26m | 18.19m | 1.59bn | 25.00 | 89.23 | 2.58 | 16.07 | 2.17 | 0.095 | 0.095 | 3.88 | 3.29 | 0.5016 | 5.72 | 4.14 | 20,748,000.00 | 1.25 | 1.85 | 1.49 | 2.45 | 40.97 | 38.59 | 2.49 | 3.20 | 1.33 | 6.75 | 0.4862 | 58.02 | 10.37 | 22.29 | 163.46 | 19.23 | 21.65 | 17.48 |
| Guangxi Wuzhou Zhongheng Group Co.,Ltd | 597.61m | 91.30m | 1.64bn | 3.99k | 17.98 | 1.55 | -- | 2.75 | 0.1691 | 0.1691 | 1.11 | 1.96 | 0.3792 | 1.30 | 6.74 | 963,400.10 | 2.94 | 7.17 | 4.27 | 8.83 | 82.87 | 81.93 | 7.76 | 18.53 | 1.72 | -- | 0.1581 | 40.58 | -3.61 | 22.31 | -24.45 | 1.59 | -13.23 | -4.51 |
| Zhejiang CONBA Pharmaceutical Co., Ltd. | 904.36m | 49.53m | 1.84bn | 9.52k | 35.71 | 2.24 | -- | 2.03 | 0.124 | 0.124 | 2.27 | 1.98 | 0.6095 | 2.00 | 4.26 | 611,494.90 | 4.45 | 4.65 | 7.66 | 7.39 | 62.93 | 67.32 | 7.30 | 7.20 | 1.01 | -- | 0.2468 | 52.38 | -12.70 | 2.19 | 231.15 | 0.5805 | 9.92 | -- |
| DSwiss Inc | 1.35m | 7.67k | 1.86bn | 6.00 | 225,000.00 | -- | 39,352.10 | 1,381.70 | 0.00004 | 0.00004 | 0.0065 | -0.0005 | 3.79 | 35.52 | 154.11 | 224,620.00 | 7.65 | -52.17 | -- | -124.42 | 27.27 | 33.27 | 2.02 | -66.69 | 0.5273 | 49.09 | -- | -- | 392.48 | 54.12 | 102.69 | -- | -14.05 | -- |
